A promising study led by Deborah Birx, MD, Chief Scientific and Medical Advisor, and Amy Carenza, BBA, Chief Commercial Officer at ActivePure, shines a spotlight on the potential of Advanced Photohydrolysis (AP) Technology in infection control. This research aims at understanding how AP systems could contribute to the mitigation of multidrug-resistant organisms and oversee infection…
In the challenging divulgence of epidemics, the occurrence of hospital-acquired infections (HAIs) from multidrug-resistant organisms (MDROs) emerges as a significant difficulty confronting global healthcare systems. Such infections generally occur 48 hours after hospital admission or post-discharge and result in prolonging hospitalization rates, enhancing medical expenses, and amplifying mortality rates. Some of the most menacing bacteria…